Skip to main content
. 2021 Sep 21;10(21):7534–7541. doi: 10.1002/cam4.4278

TABLE 3.

Occurrence of adverse reactions in the mirabegron group

Adverse reaction Mirabegron group no. (%)
Gastrointestinal symptom 2 (2.5)
Rash 2 (2.5)
Hypertension 1 (1.25)
Elevate PVR (more than 200 ml) 1 (1.25)
Palpitation 1 (1.25)
Constipation 1 (1.25)